FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109640284> ?p ?o ?g. }

• W2109640284 endingPage "132" @default.
• W2109640284 startingPage "125" @default.
• W2109640284 abstract "Objectives: To investigate the response of the various hyperplastic disorders of the endometrium to a prolonged treatment with leuprolide acetate, a gonadotropin-releasing hormone agonist (GnRH-a), plus tibolone, as add-back therapy, and further to study if the tibolone addition reduces the hypoestrogenic actions of the GnRH-analogue. Methods: We treated 26 women with histologically confirmed simple (n=9), complex (n=15) or atypical (n=2) endometrial hyperplasia (EH) for 12 months with monthly injections of 1Ampulle/3.75 mg of leuprolide acetate, followed by tibolone, 2.5 mg per day per os. Every woman unterwent a hysteroscopic evaluation and biopsy of the endometrium after 3 (in cases with atypical EH), 6 and 12 months of treatment, as well as after 12 and 24 months of follow-up. The clinical, paraclinical and laboratory course of the disease was followed-up by using of a climacteric scoring system and by testing of various parameters. Results: The histopathologic evaluation of the endometria revealed regression of EH in all women after 12 months of treatment, however, during the first 2 years of follow-up EH reappeared in four women (4/21, 19%). Bone mineral density and serum parameters did not show significant changes during treatment, whereas only a mild suffering from hypoestrogenic side-effects was noted. Conclusions: It seems that the combined GnRH-a/tibolone treatment in women with EH is a potent alternative, so far as the endometrial status and the clinical course of the disease are concerned, whereas tibolone appears to act sufficiently as add-back therapy to prolonged GnRH-a treatment. The probability of relapse of the disease during the follow-up period makes the close monitoring of the endometrium after cessation of the treatment absolutely necessary." @default.
• W2109640284 created "2016-06-24" @default.
• W2109640284 creator A5005104442 @default.
• W2109640284 creator A5009394630 @default.
• W2109640284 creator A5011093089 @default.
• W2109640284 creator A5017188196 @default.
• W2109640284 creator A5025496795 @default.
• W2109640284 creator A5034135314 @default.
• W2109640284 creator A5039093343 @default.
• W2109640284 creator A5060723302 @default.
• W2109640284 creator A5071642148 @default.
• W2109640284 creator A5079224066 @default.
• W2109640284 creator A5080684503 @default.
• W2109640284 creator A5081007156 @default.
• W2109640284 date "2004-06-01" @default.
• W2109640284 modified "2023-09-25" @default.
• W2109640284 title "Prolonged use of gonadotropin-releasing hormone agonist and tibolone as add-back therapy for the treatment of endometrial hyperplasia" @default.
• W2109640284 cites W1591340500 @default.
• W2109640284 cites W1978046639 @default.
• W2109640284 cites W1986010965 @default.
• W2109640284 cites W2006868022 @default.
• W2109640284 cites W2043402452 @default.
• W2109640284 cites W2064617101 @default.
• W2109640284 cites W2069547854 @default.
• W2109640284 cites W2072900847 @default.
• W2109640284 cites W2086213352 @default.
• W2109640284 cites W2092050711 @default.
• W2109640284 cites W2097113048 @default.
• W2109640284 cites W2098742547 @default.
• W2109640284 cites W2109064870 @default.
• W2109640284 cites W2148647732 @default.
• W2109640284 cites W2414637359 @default.
• W2109640284 cites W4237418909 @default.
• W2109640284 cites W56557460 @default.
• W2109640284 doi "https://doi.org/10.1016/j.maturitas.2003.08.008" @default.
• W2109640284 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15172086" @default.
• W2109640284 hasPublicationYear "2004" @default.
• W2109640284 type Work @default.
• W2109640284 sameAs 2109640284 @default.
• W2109640284 citedByCount "21" @default.
• W2109640284 countsByYear W21096402842012 @default.
• W2109640284 countsByYear W21096402842013 @default.
• W2109640284 countsByYear W21096402842014 @default.
• W2109640284 countsByYear W21096402842015 @default.
• W2109640284 countsByYear W21096402842016 @default.
• W2109640284 countsByYear W21096402842017 @default.
• W2109640284 countsByYear W21096402842020 @default.
• W2109640284 crossrefType "journal-article" @default.
• W2109640284 hasAuthorship W2109640284A5005104442 @default.
• W2109640284 hasAuthorship W2109640284A5009394630 @default.
• W2109640284 hasAuthorship W2109640284A5011093089 @default.
• W2109640284 hasAuthorship W2109640284A5017188196 @default.
• W2109640284 hasAuthorship W2109640284A5025496795 @default.
• W2109640284 hasAuthorship W2109640284A5034135314 @default.
• W2109640284 hasAuthorship W2109640284A5039093343 @default.
• W2109640284 hasAuthorship W2109640284A5060723302 @default.
• W2109640284 hasAuthorship W2109640284A5071642148 @default.
• W2109640284 hasAuthorship W2109640284A5079224066 @default.
• W2109640284 hasAuthorship W2109640284A5080684503 @default.
• W2109640284 hasAuthorship W2109640284A5081007156 @default.
• W2109640284 hasConcept C126322002 @default.
• W2109640284 hasConcept C126894567 @default.
• W2109640284 hasConcept C134018914 @default.
• W2109640284 hasConcept C2776363309 @default.
• W2109640284 hasConcept C2777457466 @default.
• W2109640284 hasConcept C2777689261 @default.
• W2109640284 hasConcept C2778562196 @default.
• W2109640284 hasConcept C2778575703 @default.
• W2109640284 hasConcept C2778894405 @default.
• W2109640284 hasConcept C2779742232 @default.
• W2109640284 hasConcept C29456083 @default.
• W2109640284 hasConcept C71315377 @default.
• W2109640284 hasConcept C71924100 @default.
• W2109640284 hasConceptScore W2109640284C126322002 @default.
• W2109640284 hasConceptScore W2109640284C126894567 @default.
• W2109640284 hasConceptScore W2109640284C134018914 @default.
• W2109640284 hasConceptScore W2109640284C2776363309 @default.
• W2109640284 hasConceptScore W2109640284C2777457466 @default.
• W2109640284 hasConceptScore W2109640284C2777689261 @default.
• W2109640284 hasConceptScore W2109640284C2778562196 @default.
• W2109640284 hasConceptScore W2109640284C2778575703 @default.
• W2109640284 hasConceptScore W2109640284C2778894405 @default.
• W2109640284 hasConceptScore W2109640284C2779742232 @default.
• W2109640284 hasConceptScore W2109640284C29456083 @default.
• W2109640284 hasConceptScore W2109640284C71315377 @default.
• W2109640284 hasConceptScore W2109640284C71924100 @default.
• W2109640284 hasIssue "2" @default.
• W2109640284 hasLocation W21096402841 @default.
• W2109640284 hasLocation W21096402842 @default.
• W2109640284 hasOpenAccess W2109640284 @default.
• W2109640284 hasPrimaryLocation W21096402841 @default.
• W2109640284 hasRelatedWork W1997759048 @default.
• W2109640284 hasRelatedWork W2005376244 @default.
• W2109640284 hasRelatedWork W2021202189 @default.
• W2109640284 hasRelatedWork W2027210979 @default.
• W2109640284 hasRelatedWork W2028293475 @default.
• W2109640284 hasRelatedWork W2043879443 @default.
• W2109640284 hasRelatedWork W2069420617 @default.

• next